VThunter
a database for single-cell screening of virus target cells in animal kingdom
Rat

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae,

Latin Name: Rattus norvegicus

Tested tissues: Lung, UrogenitalSinus, TotalBrain,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_1001 2019.12 10X Genomics Lung Normal 5029 Link
Vthunter_1002 2019.12 10X Genomics Lung Normal 5924 Link
Vthunter_1009 2017.11 Fluidigm C1 UrogenitalSinus Normal 114 Link
Vthunter_110073 2019.12 MARS-seq TotalBrain Normal 2304 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Dengue virus
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
Echovirus E1
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Echovirus E8
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Hepacivirus C
Lung-EC_lymph : 100.00% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
Lung-EC_cap : 98.61% ;
Lung-Meso : 98.28% ;
Lung-Meso : 96.08% ;
Lung-Secretory : 76.40% ;
Lung-Ciliated : 65.38% ;
Sindbis virus
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Influenza A virus
UrogenitalSinus-ventral mesenchymal pad : 100.00% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 98.48% ;
Lung-Mac_alv : 97.30% ;
Lung-ATI : 91.16% ;
Lung-Mac_alv : 91.11% ;
Lung-DC_CD209+ : 100.00% ;
Lung-DC_CD209+ : 86.84% ;
Lung-Secretory : 78.65% ;
Lung-Meso : 76.47% ;
Lung-Meso : 74.14% ;
Nipah henipavirus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 95.92% ;
Hendra henipavirus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 95.92% ;
Human parvovirus B19
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 66.67% ;
Human metapneumovirus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 66.67% ;
Human betaherpesvirus 5
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Mammalian orthoreovirus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Lung-Mac_alv : 88.31% ;
Lung-ATI : 83.74% ;
Lung-Mac_alv : 81.78% ;
Lung-Meso : 80.39% ;
Lung-Secretory : 79.78% ;
Adeno-associated virus 9
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Equid alphaherpesvirus 1
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 90.91% ;
Lung-Mo_Ly6c- : 69.73% ;
Lung-Mo_Ly6c- : 66.25% ;
Lung-T_CD8+ : 65.38% ;
Lung-T_CD8+ : 64.86% ;
Human gammaherpesvirus 4
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 69.70% ;
Human rotavirus strain WA
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Lung-Mac_alv : 88.31% ;
Lung-ATI : 83.74% ;
Lung-Mac_alv : 81.78% ;
Lung-Meso : 80.39% ;
Lung-Secretory : 79.78% ;
Adeno-associated virus - 2
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 66.67% ;
Adeno-associated virus - 3
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Adeno-associated virus - 8
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Vesicular stomatitis virus
Lung-DC_CD209+ : 100.00% ;
Lung-DC_CD209+ : 86.84% ;
Lung-Secretory : 78.65% ;
Lung-Meso : 76.47% ;
Lung-Meso : 74.14% ;
Classical swine fever virus
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Foot-and-mouth disease virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Lung-Secretory : 70.30% ;
Lung-ATI : 68.76% ;
Lung-Secretory : 65.17% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 66.67% ;
Simian rotavirus A strain RRV
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 100.00% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lung-Mac_alv : 87.26% ;
Lung-Secretory : 82.02% ;
Lung-SMCs : 81.11% ;
Lung-Mac_alv : 96.55% ;
Lung-ATII : 95.37% ;
Lung-Secretory : 93.26% ;
Lung-ATII : 92.00% ;
Lung-DC_CD209+ : 89.47% ;
Lung-Mac_alv : 88.31% ;
Lung-ATI : 83.74% ;
Lung-Mac_alv : 81.78% ;
Lung-Meso : 80.39% ;
Lung-Secretory : 79.78% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Venezuelan equine encephalitis virus
Lung-Mo_Ly6c+ : 100.00% ;
Lung-DC_Ccl17+ : 98.52% ;
Lung-DC_Ccl17+ : 98.51% ;
Lung-Innate_lymphoid : 98.28% ;
Lung-Mac_alv : 97.90% ;
Human mastadenovirus B
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 98.48% ;
UrogenitalSinus-ventral mesenchymal pad : 97.96% ;
Lassa mammarenavirus
Lung-Mac_alv : 97.60% ;
Lung-DC_CD209+ : 97.50% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 95.45% ;
Lung-DC_CD209+ : 92.11% ;
Lung-Mac_alv : 91.87% ;
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 78.79% ;
Enterovirus B
Lung-Mac_alv : 97.15% ;
Lung-Mac_alv : 90.51% ;
Lung-Secretory : 84.27% ;
Lung-DC_Ccl17+ : 83.58% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
Rabies lyssavirus
UrogenitalSinus-ventral mesenchymal pad : 95.92% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 86.36% ;
Japanese encephalitis virus
Lung-EC_vasc : 94.41% ;
Lung-EC_Vcam1+ : 90.00% ;
Lung-EC_vasc : 83.88% ;
Lung-EC_Vcam1+ : 83.53% ;
Lung-EC_lymph : 75.00% ;
Gibbon ape leukemia virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 92.42% ;
Lung-Mac_alv : 71.06% ;
Simian sarcoma-associated virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 92.42% ;
Lung-Mac_alv : 71.06% ;
Feline leukemia virus strain B/lambda-B1
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 92.42% ;
Lung-Mac_alv : 71.06% ;
Zika virus
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
Ebola virus
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
Marburg marburgvirus
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
Lymphocytic choriomeningitis mammarenavirus
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 78.79% ;
Severe acute respiratory syndrome coronavirus 2
Lung-Mac_alv : 91.15% ;
Lung-Mac_alv : 83.73% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 81.82% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
Lung-EC_cap : 88.89% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 84.85% ;
Lung-EC_cap : 80.12% ;
Mayaro virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 90.91% ;
Lung-Fib_Col13a1+ : 86.96% ;
Lung-Meso : 84.48% ;
Lung-Meso : 80.39% ;
Lung-Fib_Col14a1+ : 77.70% ;
Ross River virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 90.91% ;
Lung-Fib_Col13a1+ : 86.96% ;
Lung-Meso : 84.48% ;
Lung-Meso : 80.39% ;
Lung-Fib_Col14a1+ : 77.70% ;
Chikungunya virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 90.91% ;
Lung-Fib_Col13a1+ : 86.96% ;
Lung-Meso : 84.48% ;
Lung-Meso : 80.39% ;
Lung-Fib_Col14a1+ : 77.70% ;
Lung-Secretory : 76.40% ;
Lung-Secretory : 73.27% ;
Onyong-nyong virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 90.91% ;
Lung-Fib_Col13a1+ : 86.96% ;
Lung-Meso : 84.48% ;
Lung-Meso : 80.39% ;
Lung-Fib_Col14a1+ : 77.70% ;
Feline calicivirus
Lung-Mac_alv : 88.31% ;
Lung-ATI : 83.74% ;
Lung-Mac_alv : 81.78% ;
Lung-Meso : 80.39% ;
Lung-Secretory : 79.78% ;
Rhinovirus B14
Lung-ATI : 87.87% ;
Lung-ATI : 86.16% ;
Lung-EC_Vcam1+ : 82.35% ;
Lung-Mac_inter : 77.33% ;
Lung-Mac_alv : 76.01% ;
Coxsackievirus A21
Lung-ATI : 87.87% ;
Lung-ATI : 86.16% ;
Lung-EC_Vcam1+ : 82.35% ;
Lung-Mac_inter : 77.33% ;
Lung-Mac_alv : 76.01% ;
Lung-Ciliated : 65.91% ;
Suid alphaherpesvirus 1
Lung-EC_lymph : 87.50% ;
Lung-Secretory : 85.39% ;
Lung-Secretory : 70.30% ;
Lung-EC_lymph : 66.67% ;
Human alphaherpesvirus 1
Lung-EC_lymph : 87.50% ;
Lung-Secretory : 85.39% ;
Lung-Secretory : 70.30% ;
Lung-EC_lymph : 66.67% ;
Lung-Secretory : 70.30% ;
Lung-ATI : 68.76% ;
Lung-Secretory : 65.17% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Human alphaherpesvirus 2
Lung-EC_lymph : 87.50% ;
Lung-Secretory : 85.39% ;
Lung-Secretory : 70.30% ;
Lung-EC_lymph : 66.67% ;
Human papillomavirus type 16
Lung-Meso : 82.76% ;
Lung-Meso : 82.35% ;
Porcine reproductive and respiratory syndrome virus
Lung-Meso : 82.76% ;
Lung-Meso : 82.35% ;
Middle East respiratory syndrome-related coronavirus
Lung-Meso : 82.35% ;
Lung-Meso : 79.31% ;
Lung-EC_cap : 79.17% ;
Lung-EC_cap : 71.08% ;
Ecotropic murine leukemia virus
Lung-DC_CD209+ : 80.00% ;
Latino mammarenavirus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 78.79% ;
Oliveros mammarenavirus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 78.79% ;
Canine coronavirus
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
Lung-Secretory : 64.36% ;
Feline coronavirus
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
Lung-Secretory : 64.36% ;
Human coronavirus 229E
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
Infectious bronchitis virus
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
Porcine epidemic diarrhea virus
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
Transmissible gastroenteritis virus
Lung-ATII : 77.20% ;
Lung-Mac_alv : 70.61% ;
Lung-ATII : 69.74% ;
Lung-Secretory : 66.29% ;
Murine norovirus
Lung-Mac_alv : 76.46% ;
Lung-Mac_alv : 69.13% ;
Bovine leukemia virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 75.76% ;
Lung-Mac_alv : 72.59% ;
Lung-Mac_alv : 72.41% ;
UrogenitalSinus-ventral mesenchymal pad : 69.39% ;
Lung-Secretory : 67.42% ;
Jaagsiekte sheep retrovirus
Lung-EC_cap : 75.00% ;
Lung-EC_cap : 66.27% ;
Lung-EC_Vcam1+ : 65.45% ;
Coxsackievirus A9
Lung-Secretory : 70.30% ;
Lung-ATI : 68.76% ;
Lung-Secretory : 65.17% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Coxsackievirus B1
Lung-Secretory : 70.30% ;
Lung-ATI : 68.76% ;
Lung-Secretory : 65.17% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Lung-Ciliated : 65.91% ;
West Nile virus
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Human parechovirus 1
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Human mastadenovirus C
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Human gammaherpesvirus 8
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 68.18% ;
Human betaherpesvirus 7
Lung-Mo_Ly6c- : 67.99% ;
Lung-Mo_Ly6c- : 67.43% ;
Simian immunodeficiency virus
Lung-Mo_Ly6c- : 67.99% ;
Lung-Mo_Ly6c- : 67.43% ;
Human immunodeficiency virus 1
Lung-Mo_Ly6c- : 67.99% ;
Lung-Mo_Ly6c- : 67.43% ;
Human immunodeficiency virus 2
Lung-Mo_Ly6c- : 67.99% ;
Lung-Mo_Ly6c- : 67.43% ;
Enterovirus A71
TotalBrain-Immune cells : 67.97% ;
Feline endogenous virus RD114
Lung-Mac_alv : 66.87% ;
Baboon endogenous virus strain M7
Lung-Mac_alv : 66.87% ;
Simian type D retrovirus -Tsukuba
Lung-Mac_alv : 66.87% ;
Varicella Zoster Virus
Lung-EC_lymph : 66.67% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 65.15% ;
Human alphaherpesvirus 3
Lung-EC_lymph : 66.67% ;
UrogenitalSinus-smooth muscle, peri-urethral mesenchyme and urethral epithelium : 65.15% ;
Echovirus E6
Lung-Ciliated : 65.91% ;
Echovirus E7
Lung-Ciliated : 65.91% ;
Echovirus E11
Lung-Ciliated : 65.91% ;
Echovirus E12
Lung-Ciliated : 65.91% ;
Echovirus E13
Lung-Ciliated : 65.91% ;
Echovirus E20
Lung-Ciliated : 65.91% ;
Echovirus E21
Lung-Ciliated : 65.91% ;
Echovirus E29
Lung-Ciliated : 65.91% ;
Echovirus E33
Lung-Ciliated : 65.91% ;
Enterovirus D68
Lung-Ciliated : 65.91% ;
Coxsackievirus B3
Lung-Ciliated : 65.91% ;
Coxsackievirus B5
Lung-Ciliated : 65.91% ;
Human enterovirus 70
Lung-Ciliated : 65.91% ;
Encephalomyocarditis virus
Lung-EC_Vcam1+ : 65.45% ;
Rhinovirus C
Lung-Ciliated : 65.38% ;
Respiratory syncytial virus
TotalBrain-Immune cells : 64.71% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China